These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2872489)

  • 1. Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia.
    Wheeler DC; Smith B; Walls J
    Lancet; 1986 Jun; 1(8494):1380. PubMed ID: 2872489
    [No Abstract]   [Full Text] [Related]  

  • 2. Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia.
    O'Donovan R; Baldwin D; Hammer M; Moniz C; Parsons V
    Lancet; 1986 Apr; 1(8486):880-2. PubMed ID: 2870354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norfloxacin and absorption of magnesium-aluminum.
    Noyes M; Polk RE
    Ann Intern Med; 1988 Jul; 109(2):168-9. PubMed ID: 3382110
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation in healthy volunteers to evaluate serum concentrations and urinary excretions of aluminium, magnesium, calcium and phosphate after multiple administration of hydrotalcit (Talcid) suspension.
    Wölke E; Seiberling M; Schepers C; Roos U; Franke H; Bernhard I
    Boll Chim Farm; 1993; 132(7):234-40. PubMed ID: 8398056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnesium hydroxide treatment of hyperphosphatemia in chronic hemodialysis patients with an aluminum overload].
    Roujouleh H; Lavaud S; Toupance O; Melin JP; Chanard J
    Nephrologie; 1987; 8(2):45-50. PubMed ID: 3614505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of aluminium and magnesium in animals and man after administration of high doses of almagate.
    Jauregui J; Segura J
    Arzneimittelforschung; 1984; 34(10A):1364-6. PubMed ID: 6548921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term use of magnesium hydroxide as a phosphate binder in patients on hemodialysis.
    Oe PL; Lips P; van der Meulen J; de Vries PM; van Bronswijk H; Donker AJ
    Clin Nephrol; 1987 Oct; 28(4):180-5. PubMed ID: 3690899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical instillation of maalox for the treatment of hemorrhagic cystitis.
    Kawagoe K; Kawana T
    Asia Oceania J Obstet Gynaecol; 1989 Mar; 15(1):107-8. PubMed ID: 2735834
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of the side effects of aspirin. Value of the combination of aspirin with Maalox].
    Hecht Y
    Med Chir Dig; 1981; 10(7):633-6. PubMed ID: 7329130
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of antacid on levodopa therapy.
    Lau E; Waterman K; Glover R; Schulzer M; Calne DB
    Clin Neuropharmacol; 1986; 9(5):477-9. PubMed ID: 3768869
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.
    Krishna R; East L; Larson P; Valiathan C; Butterfield K; Teng Y; Hernandez-Illas M
    J Pharm Pharmacol; 2016 Nov; 68(11):1359-1365. PubMed ID: 27671833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of an antacid plus antispasmodic combination and aluminium hydroxide in dyspepsia.
    Kagan G; Rose R
    Curr Med Res Opin; 1977; 5(2):200-3. PubMed ID: 340140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma aluminium levels in patients on maintenance haemodialysis fall when oral aluminium hydroxide is withdrawn.
    Wallace MR; Pybus J
    N Z Med J; 1983 Oct; 96(742):793-5. PubMed ID: 6578451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic single-dose oral antacid therapy in the preoperative period--comparison of cimetidine and Maalox.
    Detmer MD; Pandit SK; Cohen PJ
    Anesthesiology; 1979 Sep; 51(3):270-3. PubMed ID: 475033
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the neutralizing activity on gastric acidity of a carbenoxolone-antacid formulation using computerized gastric pH-metry in healthy volunteers].
    Passaretti S; Tittobello A
    Clin Ter; 1988 Mar; 124(5):357-61. PubMed ID: 2974345
    [No Abstract]   [Full Text] [Related]  

  • 16. [Kinetics of aluminum absorption and serum concentration in chronic renal insufficiency].
    Sárszegi Z; Jobst K; Nagy J
    Orv Hetil; 2000 Aug; 141(35):1915-7. PubMed ID: 11019592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fatal case of aluminium encephalopathy in a patient with severe chronic renal failure not on dialysis.
    Zatta P; Zambenedetti P; Reusche E; Stellmacher F; Cester A; Albanese P; Meneghel G; Nordio M
    Nephrol Dial Transplant; 2004 Nov; 19(11):2929-31. PubMed ID: 15496577
    [No Abstract]   [Full Text] [Related]  

  • 18. Substitution of aluminium hydroxide by high doses of calcium carbonate in patients on chronic haemodialysis: disappearance of hyperaluminaemia and equal control of hyperparathyroidism.
    Moriniere P; Roussel A; Tahiri Y; de Fremont JF; Maurel G; Jaudon MC; Gueris J; Fournier A
    Proc Eur Dial Transplant Assoc; 1983; 19():784-7. PubMed ID: 6878265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment of hemorrhagic cystitis after radiation therapy with intravesical instillation of aluminium hydroxide gel and magnesium hydroxide: report of a case].
    Kawamura N; Kakuta Y; Fukuhara S; Imazu T; Hara T; Yamaguchi S
    Hinyokika Kiyo; 2008 Mar; 54(3):239-41. PubMed ID: 18411783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Administration of colloidal aluminium hydroxide to patients under chronic hemodialysis].
    Vokrouhlická O; Erben J; Zahradník J; Dvoráková-Bastecká D
    Cas Lek Cesk; 1977 May; 116(19):594-7. PubMed ID: 880597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.